Nabi Reports Positive Phase IIb Results For Anti-Smoking Vaccine NicVAX
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm is in competition with Novartis/Cytos to get a smoking vaccine to market.
You may also be interested in...
Nabi Sells Biologics Business To German Plasma Protein Firm Biotest
Nabi met with FDA Sept. 11 concerning components and a timeline for completion of its Nabi-HB IV BLA, pending at the agency since 2002.
Nabi Sells Biologics Business To German Plasma Protein Firm Biotest
Nabi met with FDA Sept. 11 concerning components and a timeline for completion of its Nabi-HB IV BLA, pending at the agency since 2002.
Two Nicotine Addiction Vaccines On Phase III Racetrack
Novartis partners with Cytos on CYT002-NicQb, while Nabi looks to partner NicVax prior to pivotal trials in second half.